⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNTM News
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Quantum BioPharma Provides Corporate Update
globenewswire.com
QNTM
Form 8-K
sec.gov
GRML
GRMLW
GRDX
QNTM
LIXT
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
globenewswire.com
QNTM
Quantum Metric Named Most Valuable Pioneer in the QKS AI Maturity Matrix™: Product Analytics Software, 2026
prnewswire.com
QNTM
Quantum Metric's Record Sales Performance Signals the End of Dashboards for Digital Experience Analytics
globenewswire.com
QNTM
Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied
globenewswire.com
QNTM
Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
globenewswire.com
QNTM
Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
globenewswire.com
QNTM
Quantum Biopharma Provides Corporate Update
globenewswire.com
QNTM
Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status
globenewswire.com
QNTM